Skip to content

Study · Measured the body's own peptide · 2019

1 result

Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Romero CA, Kumar N, Nakagawa P, Worou ME, Liao TD, Peterson EL, Carretero OA

American journal of physiology. Renal physiology7 Nov 2018Cited by 18 (Europe PMC)

PMID30403163 (opens in a new tab)PMCIDPMC6383198 (opens in a new tab)DOI10.1152/ajprenal.00270.2018 (opens in a new tab)PepBankPUB-30403163
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01AnimalEndogenous levelAnimal study (in vivo)Mechanism

    In Sprague-Dawley rats, the Tβ4 precursor and the releasing enzymes meprin-α and POP were expressed in the kidneys.

    In plain wordsIn rats, the body's own thymosin beta‑4 precursor and its releasing enzymes were present in the kidneys.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableTβ4 precursor expression in kidney
    Study

    ratn: not reported in source

    Sprague-Dawley rat kidney
    Outcome group
    Receptor activity and mechanism · Kidney and urinary

    Source sentences

    Summary
    The Tβ4 precursor and the releasing enzymes meprin-α and POP were expressed in the kidneys.
    1 context sentence
    Summary · context
    We determined the presence of Tβ4, meprin-α, and POP in the kidneys of Sprague-Dawley rats.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.